Adeka (4401) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
10 Mar, 2026Executive summary
Net sales for FY2024 3Q rose 3.5% year-over-year to ¥296.3 billion, with operating profit up 25.1% to ¥30.0 billion and net profit attributable to owners up 16.7% to ¥19.2 billion.
Growth was driven by strong performance in chemicals, especially polymer additives and electronic materials, while food products and life science segments saw declines in sales but improved profitability.
Overseas sales ratio increased to 55.5%, reflecting continued international expansion.
The global economy showed gradual recovery, led by the U.S., despite ongoing uncertainties from China and geopolitical risks.
Financial highlights
Operating profit increased by ¥6.0 billion year-over-year, mainly due to higher sales volume and improved net pricing.
EPS for 3Q was ¥188.4, up from ¥161.0 in the prior year.
Gross profit increased to ¥84,034 million from ¥73,898 million year-over-year.
Ordinary profit rose 20.7% to ¥29,672 million, and comprehensive income was ¥23,922 million.
Cash and deposits rose by ¥9.8 billion from March to December 2024, while current liabilities decreased by ¥12.5 billion.
Outlook and guidance
FY2024 full-year net sales forecast remains at ¥426.0 billion, with operating profit projected at ¥41.1 billion and net profit at ¥24.5 billion.
Dividend forecast for FY2024/FY2025 is ¥97 per share, up from ¥90 in the previous year.
FY2026 targets include net sales of ¥500 billion and operating profit of ¥53.0 billion.
No changes to the previously announced forecast.
Latest events from Adeka
- Profit and sales rose, led by Life Science, with stable outlook and higher dividend forecast.4401
Q1 202610 Mar 2026 - Life Science strength drove profit growth, offsetting Chemicals and Food Products weakness.4401
Q2 202610 Mar 2026 - Profits and sales grew, led by Chemicals and Food Products, with raised outlook and Life Science loss.4401
Q1 202510 Mar 2026 - Strategic investments and innovation in semiconductor materials target rapid global growth.4401
Investor presentation10 Mar 2026 - Strong 1H FY2024 results and Chemicals growth led to higher guidance and dividend forecasts.4401
Q2 202510 Mar 2026 - Record sales and profit growth driven by Chemicals, with continued expansion and higher dividends forecast.4401
Q4 202510 Mar 2026 - Profit rose on strong Life Science and Environmental Materials, offsetting Chemicals weakness.4401
Q3 202610 Mar 2026